{"id":"W2398715868","doi":"10.1177/1756287215592288","title":"Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapy","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Abiraterone acetate; Enzalutamide; Cabazitaxel; Prostate cancer; Docetaxel; Oncology; Internal medicine; Adverse effect; Chemotherapy; Androgen deprivation therapy; Cancer; Pharmacology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000359074,0.0003903738,0.0009912295,0.00202174,0.0001957277,0.0006071031,0.0005462778,0.0004761946,0.002679059],"category_scores_gemma":[0.0006002577,0.0001767161,0.0005091759,0.001476122,0.0002405968,0.0004861854,0.0003649039,0.001101389,0.0009552449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003953969,"about_ca_system_score_gemma":0.0008077899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001281818,"about_ca_topic_score_gemma":0.003354214,"domain_scores_codex":[0.9998066,0.00003662799,0.00004053793,0.0000239873,0.00007714301,0.00001513299],"domain_scores_gemma":[0.9997987,0.0001081489,0.00003745731,0.000004938364,0.00003744331,0.00001336026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000125426,0.00007209749,0.0002354388,0.0272343,0.000138432,0.0002967371,0.00007601661,0.0003151414,0.001214765,0.001190848,0.01377476,0.9553261],"study_design_scores_gemma":[0.0000578087,0.0001834209,0.001930293,0.01034924,0.0003143285,0.003322839,0.00008210617,0.0001263745,0.000682663,0.001150812,0.9817794,0.00002059376],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001932544,0.9990078,0.00003998464,0.00007362357,0.00005388779,0.000003283595,0.00001031966,0.000003821958,0.0006141348],"genre_scores_gemma":[0.001256416,0.9982246,0.00008697539,0.000082824,0.00005609371,0.000003374766,0.00002021524,8.925159e-7,0.0002686409],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002679059,"threshold_uncertainty_score":0.008962333,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07728953142386998,"score_gpt":0.4469508642662002,"score_spread":0.3696613328423302,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}